In June we move into the entire fifth floor of the GoCo Clinic building and established a unique “from bench-to-bed” set-up with an R&D department, a Ph2 clinical trial unit (Ribocure Clinic) and an in vitro human cell lab.
Ribo’s siRNA asset RBD5044 receives Clinical Trial Authorization from Swedish MPA for a Phase II trial in patients with mixed dyslipidemia
On October 28, 2024, Ribocure Pharmaceuticals AB and Suzhou Ribo